Ticker

Analyst Price Targets — PGEN

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
August 5, 2026 10:01 amH.C. Wainwright$18.00$6.53TheFly Precigen price target raised to $18 from $14 at H.C. Wainwright
May 28, 2026 10:01 amH.C. Wainwright$14.00$4.40TheFly Precigen price target raised to $14 from $11 at H.C. Wainwright
May 14, 2026 10:09 amH.C. Wainwright$11.00$4.15TheFly Precigen price target raised to $11 from $10 at H.C. Wainwright
August 9, 2022 6:25 amH.C. Wainwright$6.00$2.05Benzinga HC Wainwright & Co. Maintains Buy on Precigen, Lowers Price Target to $6

Latest News for PGEN

5 Biotech Stocks Worth Adding to Your Portfolio Now

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position HALO, RGEN, IOVA, ARQT and PGEN in this volatile sector.

Zacks Investment Research • Aug 26, 2026
Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers

Biotech in the News: The Longview The Company's New Drug, the First FDA-Approved Therapy for Recurrent Respiratory Papillomatosis (RRP), is Delivering Strong Commercial Traction While Highlighting the Broader Potential of Its Proprietary AdenoVerse Therapeutic Platform in HPV-Associated Cancers GERMANTOWN, MD / ACCESS Newswire / August 25, 2026 / For Germantown, MD-based Precigen Inc. (NASDAQ:PGEN), the second…

Accesswire • Aug 25, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for PGEN.

No House trades found for PGEN.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top